Published in Public Health Rep on April 24, 1984
A computer network for the surveillance of communicable diseases: the French experiment. Am J Public Health (1986) 5.38
STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of US physicians. Am J Public Health (2002) 2.85
Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis (2010) 2.45
A population-based estimate of the substantial burden of diarrhoeal disease in the United States; FoodNet, 1996-2003. Epidemiol Infect (2007) 2.22
Utilization of case definitions and laboratory reporting in the surveillance of notifiable communicable diseases in the United States. Am J Public Health (1985) 2.01
Completeness of tuberculosis case reporting, San Juan and Caguas Regions, Puerto Rico, 1992. Public Health Rep (1996) 1.93
The selection and definition of targeted work-related conditions for surveillance under SENSOR. Am J Public Health (1989) 1.56
Public health 101 for informaticians. J Am Med Inform Assoc (2001) 1.51
Impact of two interventions on timeliness and data quality of an electronic disease surveillance system in a resource limited setting (Peru): a prospective evaluation. BMC Med Inform Decis Mak (2009) 1.45
Evaluation of knowledge resources for public health reporting logic: Implications for knowledge authoring and management. Online J Public Health Inform (2011) 1.43
The surveillance of communicable disease in Vermont: who reports? Public Health Rep (1991) 1.40
Private doctors' practices, knowledge, and attitude to reporting of communicable diseases: a national survey in Taiwan. BMC Infect Dis (2009) 1.20
Improving disease reporting in Los Angeles County: trial and results. Public Health Rep (1988) 1.18
Physician privacy concerns when disclosing patient data for public health purposes during a pandemic influenza outbreak. BMC Public Health (2011) 1.17
A secure protocol for protecting the identity of providers when disclosing data for disease surveillance. J Am Med Inform Assoc (2011) 1.10
Reporting of communicable diseases by university physicians. Public Health Rep (1991) 1.10
Urgent care providers' knowledge and attitude about public health reporting and pertussis control measures: implications for informatics. J Public Health Manag Pract (2009) 1.08
Awareness and knowledge of disease surveillance and notification by health-care workers and availability of facility records in Anambra state, Nigeria. Niger Med J (2012) 1.05
Integrating clinical practice and public health surveillance using electronic medical record systems. Am J Public Health (2012) 1.01
Environmental exposures and invasive meningococcal disease: an evaluation of effects on varying time scales. Am J Epidemiol (2009) 0.94
The effect of message type on physician compliance with disease reporting requirements. Public Health Rep (2007) 0.87
Understanding the limits of large datasets. J Cancer Educ (2012) 0.85
Strengthening public health and primary care collaboration through electronic health records. Am J Public Health (2012) 0.84
Outbreak bias in illness reporting and case confirmation in ciguatera fish poisoning surveillance in south Florida. Public Health Rep (2007) 0.84
Evaluation of HIV incidence surveillance in New York City, 2006. Public Health Rep (2011) 0.84
Innovative uses for syndromic surveillance. Emerg Infect Dis (2010) 0.84
Understanding attitudes, barriers and challenges in a small island nation to disease and partner notification for HIV and other sexually transmitted infections: a qualitative study. BMC Public Health (2015) 0.84
Notifiable disease reporting among public sector physicians in Nigeria: a cross-sectional survey to evaluate possible barriers and identify best sources of information. BMC Health Serv Res (2014) 0.77
Communicable Disease Reporting Systems in the World: A Systematic Review Article. Iran J Public Health (2015) 0.77
Disease reporting by physicians in New York City. Bull N Y Acad Med (1988) 0.75
Detection of events of public health importance under the international health regulations: a toolkit to improve reporting of unusual events by frontline healthcare workers. BMC Public Health (2011) 0.75
Differential West Nile fever ascertainment in the United States: a multilevel analysis. Am J Trop Med Hyg (2010) 0.75
Knowledge, attitudes, and practices for diagnosing breakthrough varicella in the outpatient setting. Public Health Rep (2012) 0.75
Imported malaria in portugal 2000-2009: a role for hospital statistics for better estimates and surveillance. Malar Res Treat (2014) 0.75
Evaluation of a communications campaign to increase physician reporting to a surveillance system. Public Health Rep (2011) 0.75
Health Care Provider Knowledge and Attitudes Regarding Reporting Diseases and Events to Public Health Authorities in Tennessee. J Public Health Manag Pract (2016) 0.75
The reporting of communicable diseases. Am J Epidemiol (1977) 7.76
National survey of venereal disease treated by physicians in 1968. JAMA (1970) 4.78
Innovative communicable disease reporting. HSMHA Health Rep (1971) 4.67
NATIONAL SURVEY OF VENEREAL DISEASE TREATMENT. JAMA (1963) 3.82
Physicians' attitudes toward venereal disease reporting. A survey by the National Opinion Research Center. JAMA (1967) 3.57
Shigella surveillance in a large metropolitan area: assessment of a passive reporting system. Am J Public Health (1980) 3.43
Proposed toll-free telephone reporting of notifiable diseases. Health Serv Rep (1972) 2.12
Reporting of gonorrhea by private physicians: a behavioral study. Am J Public Health (1980) 1.76
Respiratory syncytial virus and influenza. Practical community surveillance. Am J Dis Child (1976) 1.36
New reporting system aids epidemiologists. Hospitals (1979) 1.08
On reports and rapport in VD control. Am J Public Health (1980) 1.01
Ohio's communicable diseases: why aren't they being reported? Ohio State Med J (1980) 1.00
Building an effective doctor-patient relationship: from patient satisfaction to patient participation. Soc Sci Med (1985) 2.15
Tuberculosis preventive therapy for HIV-infected people in sub-Saharan Africa is cost-effective. AIDS (1999) 2.11
Zidovudine prophylaxis for needlestick exposure to human immunodeficiency virus: a decision analysis. J Gen Intern Med (1990) 1.46
Completing tuberculosis prophylaxis in jail: targeting treatment and comparison of rifampin/pyrazinamide with isoniazid regimens. Int J Tuberc Lung Dis (2004) 1.43
Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital. Arch Intern Med (1994) 1.22
The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactors. JAMA (1986) 1.14
Should the risk of acquired immunodeficiency syndrome deter hepatitis B vaccination? A decision analysis. JAMA (1984) 1.11
Anticoagulation clinics and the monitoring of anticoagulant therapy. Int J Cardiol (1988) 1.01
The safety of Bacille Calmette-Guérin vaccination in HIV infection and AIDS. AIDS (1993) 0.95
Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis. Surgery (1989) 0.94
Lumbar puncture in asymptomatic late syphilis. An analysis of the benefits and risks. Arch Intern Med (1985) 0.86
Anomalous pulmonary venous connexions of left lung associated with valvular heart disease. Report of two cases. Br Heart J (1972) 0.82
Tuberculin screening: cost-effectiveness analysis of various testing schedules. Am J Prev Med (1990) 0.80
A model for physicians' therapeutic decision making. Arch Intern Med (1987) 0.79
Screening for lead toxicity among autobody repair workers. Am J Ind Med (1982) 0.78
A medical school's involvement in the development of a community-based health center. J Community Health (1982) 0.78
Hearing loss screening in the neonatal intensive care unit: auditory brain stem response versus Crib-O-Gram; a cost-effectiveness analysis. Ear Hear (1987) 0.77
BCG vaccination to prevent tuberculosis in health care workers: a decision analysis. Prev Med (1997) 0.77
Iatrogenic coronary artery stenosis following coronary stenting. Catheter Cardiovasc Interv (1999) 0.77
Tuberculosis chemoprophylaxis for diabetics: are the benefits of isoniazid worth the risk? Mt Sinai J Med (1985) 0.76
Survival of elderly patients with transfusion-related acquired immunodeficiency syndrome. J Am Geriatr Soc (1993) 0.76
AIDS drug regimens that are worth their costs. JAMA (1998) 0.75
Life expectancies: population or person? Ann Intern Med (1989) 0.75
Isoniazid prophylaxis for young adults. Arch Intern Med (1991) 0.75
Benefits of isoniazid preventive therapy. Arch Intern Med (1996) 0.75
Catatonia in a patient with AIDS-related dementia. J Clin Psychiatry (1992) 0.75
Acute suppurative thyroiditis caused by Serratia marcescens. J Infect Dis (1984) 0.75
The effect of Pneumocystis carinii pneumonia prophylaxis regimens on the incidence of bacterial infections in HIV-infected patients. AIDS (1993) 0.75
Discounting, isoniazid, and tuberculosis. JAMA (1987) 0.75
Complications of surgery in HIV-infected patients. AIDS (1998) 0.75
Community participation in New York City: success or failure? Am J Prev Med (1988) 0.75
Kurt W. Deuschle and community medicine: clinical care, statistical compassion, community empowerment. Mt Sinai J Med (1992) 0.75